Bagundol, Kate Cassidy G.
HRN: 25-53-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2025
CEFUROXIME 750MG (VIAL)
01/29/2025
02/04/2025
IV
750mg
Q8
Bone Fracture
Waiting Final Action
Indication: Culture-directed Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes